Seller: Basi6 International, Irving, TX, U.S.A.
Condition: Brand New. New.SoftCover International edition. Different ISBN and Cover image but contents are same as US edition.Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Seller: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Hardcover. Condition: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Seller: SHIMEDIA, Brooklyn, NY, U.S.A.
Condition: New. Satisfaction Guaranteed or your money back.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New.
Seller: moluna, Greven, Germany
Condition: New. Mark Rogge, David R. TaftPreclinical Drug Development, Second Edition discusses the broad and complicated realm of preclinical drug development. Topics range from assessment of pharmacology and toxicology to industry trends and regul.
Seller: ECOSPHERE, Champs sur marne, France
Couverture rigide. Condition: Neuf. 2ème Édition.
Language: English
Published by Taylor & Francis Group, 2009
ISBN 10: 1420084720 ISBN 13: 9781420084726
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. pp. 536 Illus. This item is printed on demand.
Language: English
Published by Taylor & Francis, CRC Press, 2009
ISBN 10: 1420084720 ISBN 13: 9781420084726
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Preclinical Drug Development, Second Edition discusses the broad and complicated realm of preclinical drug development. Topics range from assessment of pharmacology and toxicology to industry trends and regulatory expectations to requirements that support clinical trials. Highlights of the Second Edition include: PharmacokineticsModeling and simulationFormulation and routes of administrationToxicity evaluationsThe assessment of drug absorption and metabolismInterspecies scaling Lead molecule selection and optimization via profilingScreening using in silico and in vitro toxicity evaluations The book also includes case studies on preclinical pharmacokinetic-pharmacodynamic modeling and simulation in drug development, a review of ICH preclinical guidelines, and experimental methods used to study membrane drug transport and metabolism. This guide is a fundamental resource for medicinal chemists, biologists, and other specialists in the drug development sciences. 380 pp. Englisch.
Language: English
Published by Taylor & Francis, CRC Press, 2009
ISBN 10: 1420084720 ISBN 13: 9781420084726
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Preclinical Drug Development, Second Edition discusses the broad and complicated realm of preclinical drug development. Topics range from assessment of pharmacology and toxicology to industry trends and regulatory expectations to requirements that support clinical trials. Highlights of the Second Edition include: PharmacokineticsModeling and simulationFormulation and routes of administrationToxicity evaluationsThe assessment of drug absorption and metabolismInterspecies scaling Lead molecule selection and optimization via profilingScreening using in silico and in vitro toxicity evaluations The book also includes case studies on preclinical pharmacokinetic-pharmacodynamic modeling and simulation in drug development, a review of ICH preclinical guidelines, and experimental methods used to study membrane drug transport and metabolism. This guide is a fundamental resource for medicinal chemists, biologists, and other specialists in the drug development sciences.